1. Home
  2. UEIC vs NSRX Comparison

UEIC vs NSRX Comparison

Compare UEIC & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Electronics Inc.

UEIC

Universal Electronics Inc.

HOLD

Current Price

$3.76

Market Cap

48.3M

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$4.79

Market Cap

53.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UEIC
NSRX
Founded
1986
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.3M
53.5M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
UEIC
NSRX
Price
$3.76
$4.79
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$9.25
$20.50
AVG Volume (30 Days)
48.6K
2.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
75.79
N/A
EPS
N/A
N/A
Revenue
$394,879,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.69
$4.90
52 Week High
$7.90
$9.99

Technical Indicators

Market Signals
Indicator
UEIC
NSRX
Relative Strength Index (RSI) 41.31 40.31
Support Level $3.68 N/A
Resistance Level $3.79 $6.39
Average True Range (ATR) 0.17 0.73
MACD -0.05 -0.01
Stochastic Oscillator 5.08 10.78

Price Performance

Historical Comparison
UEIC
NSRX

About UEIC Universal Electronics Inc.

Universal Electronics Inc is a United States-based company that principally designs, develops, manufactures, ships, and supports control and sensor technology solutions and a broad line of universal control systems, audio-video (AV) accessories, wireless security, and smart home products that are used by the world's brands in the video services, consumer electronics, security, home automation, climate control and home appliance markets. It generates its total revenue from the United States.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: